1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. JUBILANT PHARMOVA LTD.

Jubilant Pharmova Ltd. NSE: JUBLPHARMA | BSE: 530019

Jubilant Pharmova Ltd. Live Share Price Today, Share Analysis and Chart

Value Stock, Under Radar
about

Incorporated in 1978, Jubilant Pharmova is engaged in radiopharma, allergy immunotherapy, contract development and manufacturing of sterile injectable, generics, contract research development and manufacturing and proprietary novel drugs businesses. ...

Read More

867.85 -13.20 (-1.50%)

33.75% Fall from 52W High

134.1K NSE+BSE Volume

NSE 09 May, 2025 3:31 PM (IST)

Watchlist

Portfolio

Alert

Share
Board Meeting
The next board meeting for Jubilant Pharmova Ltd. is on 16 May 2025 for the purpose of Audited Results & Final Dividend See details
Loading... You have run out of DVM views! Check usage
Subscribe now to see details
Durability score
High Financial Strength
70.0 / 100
Valuation Score
Affordable Valuation
60.5 / 100
Momentum Score
Technically Bearish
28.8 / 100
Value Stock, Under Radar These stocks are strong in quality and valuation, but score weak in technical aspects. Hence, it is better to wait for the stock to change their momentum. View Similar Embed DVM
Analyst Price Target
1,310
1Yr Price target upside is 51%
2 analysts

15

S

9

W

4

O

1

T

SWOT Analysis

Jubilant Pharmova Live Price Chart

Switch to TradingView


Loading Fundamental data..


Loading data..

Earnings Conference Calls, Investor Presentations and Annual Reports

24 Feb, 2025 BSE INDIA
Jubilant Pharmova Ltd - 530019 - Audio Recording Of Investors / Analysts Meeting
Jubilant Pharmova Ltd - 530019 - Audio Recording Of Investors / Analysts Meeting
pdf link
09 Feb, 2023 BSE INDIA
Jubilant Pharmova Ltd - 530019 - Announcement under Regulation 30 (LODR)-Earnin…
Jubilant Pharmova Ltd - 530019 - Announcement under Regulation 30 (LODR)-Earnin…
pdf link
03 Feb, 2023 BSE INDIA
Jubilant Pharmova Ltd - 530019 - Announcement under Regulation 30 (LODR)-Earnin…
Jubilant Pharmova Ltd - 530019 - Announcement under Regulation 30 (LODR)-Earnin…
pdf link
31 Oct, 2022 BSE INDIA
Jubilant Pharmova Ltd - 530019 - Announcement under Regulation 30 (LODR)-Analys…
Jubilant Pharmova Ltd - 530019 - Announcement under Regulation 30 (LODR)-Analys…
pdf link
22 Oct, 2022 BSE INDIA
Jubilant Pharmova Ltd - 530019 - Announcement under Regulation 30 (LODR)-Analys…
Jubilant Pharmova Ltd - 530019 - Announcement under Regulation 30 (LODR)-Analys…
pdf link
08 Aug, 2022 BSE INDIA
Jubilant Pharmova Ltd - 530019 - Announcement under Regulation 30 (LODR)-Earnin…
Jubilant Pharmova Ltd - 530019 - Announcement under Regulation 30 (LODR)-Earnin…
pdf link
02 Aug, 2022 TRENDLYNE
Results Earnings Call for Q1FY23 of Jubilant Pharmova
Results Earnings Call for Q1FY23 of Jubilant Pharmova
audio video link
02 Aug, 2022 BSE INDIA
Jubilant Pharmova Ltd - 530019 - Announcement under Regulation 30 (LODR)-Earnin…
Jubilant Pharmova Ltd - 530019 - Announcement under Regulation 30 (LODR)-Earnin…
pdf link
02 Jun, 2022 BSE INDIA
Jubilant Pharmova Ltd - 530019 - Announcement under Regulation 30 (LODR)-Earnin…
Jubilant Pharmova Ltd - 530019 - Announcement under Regulation 30 (LODR)-Earnin…
pdf link
28 May, 2022 TRENDLYNE
Earnings Call for Q4FY22 of Jubilant Pharmova
Earnings Call for Q4FY22 of Jubilant Pharmova
video link
28 May, 2022 BSE INDIA
Jubilant Pharmova Ltd - 530019 - Announcement under Regulation 30 (LODR)-Earnin…
Jubilant Pharmova Ltd - 530019 - Announcement under Regulation 30 (LODR)-Earnin…
pdf link
05 Feb, 2022 TRENDLYNE
Earnings Call for Q3FY22 Jubilant Pharmova
Earnings Call for Q3FY22 Jubilant Pharmova
audio video link
All Earnings Calls
Annual Report Mar-2024
pdf
Annual Report Mar-2023
pdf
Annual Report Mar-2022
pdf
Annual Report Mar-2021
pdf
Annual Report Mar-2020
pdf
Annual Report Mar-2019
pdf
Annual Report Mar-2018
pdf
Annual Report Mar-2017
pdf
Annual Report Mar-2016
pdf
Annual Report Mar-2015
pdf
Annual Report Mar-2014
pdf
Annual Report Mar-2013
pdf
Annual Report Mar-2012
pdf
05 May, 2025 INDIA RATINGS
India Ratings Assigns Jubilant Pharmovas CP IND A1+; Affirms Bank Facilities at…
link
09 Dec, 2024 INDIA RATINGS
India Ratings Revises Outlook on Jubilant Pharmovas Bank Facilities to Stable; …
link
20 Oct, 2023 INDIA RATINGS
India Ratings Discontinues Voluntary Issuer Rating Disclosure due to Regulatory…
link
26 Dec, 2022 INDIA RATINGS
India Ratings Assigns Jubilant Pharmova IND AA+/Stable and its Proposed CP IND …
link
26 May, 2021 INDIA RATINGS
India Ratings Upgrades Jubilant Pharmova to IND AA+/Stable; Off RWE & Withdraws…
link
06 May, 2021 CRISIL RATINGS
Jubilant Pharmova Limited
Jubilant Pharmova Limited:Long-term rating removed from 'Watch Developing '; Ratings withdrawn
link
10 Nov, 2020 CRISIL RATINGS
Jubilant Life Sciences Limited
Jubilant Life Sciences Limited: Long-term rating continues on 'Watch Developing'; CP reaffirmed
link
29 Oct, 2020 INDIA RATINGS
India Ratings Maintains Jubilant Life Sciences on RWE
link
06 Aug, 2020 INDIA RATINGS
India Ratings Maintains Jubilant Life Sciences on RWE; Withdraws NCD Rating
link
04 Nov, 2019 INDIA RATINGS
India Ratings Places Jubilant Life Sciences on RWE
link
15 Oct, 2019 INDIA RATINGS
India Ratings Affirms Jubilant Life Sciences and its NCDs at IND AA/Stable
link
13 May, 2019 INDIA RATINGS
India Ratings Affirms Jubilant Life Sciences Short-Term Debt/CP at IND A1+
link
All Credit Ratings
18 Jun, 2021 BSE INDIA
Jubilant Pharmova Ltd - 530019 - Announcement under Regulation 30 (LODR)-Invest…
Jubilant Pharmova Ltd - 530019 - Announcement under Regulation 30 (LODR)-Invest…
pdf link
03 Feb, 2015 BSE INDIA
Announces Q3 Results, Results Press Release, Investors Presentation & Limited R…
Announces Q3 Results, Results Press Release, Investors Presentation & Limited R…
pdf link

Jubilant Pharmova Ltd. FAQ

How is Jubilant Pharmova Ltd. today?
Jubilant Pharmova Ltd. today is trading in the red, and is down by -1.50% at 867.85.
Jubilant Pharmova Ltd. is currently trading down -1.50% on an intraday basis. In the past week the stock fell -4.31%. stock has been down -13.22% in the past quarter and rose 27.78% in the past year. You can view this in the overview section.